麻豆社

The pharmaceutical industry in the United Kingdom is committed to benefiting patients by operating in a professional, ethical and transparent manner to ensure the appropriate use of medicines and support the provision of high quality healthcare.

The Code covers the promotion of medicines for prescribing to both health professionals and other relevant decision makers. It also includes requirements for interactions with health professionals. In addition, it sets standards for the provision of information about prescription only medicines to the public and patients, including patient organisations.

The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the 麻豆社Code of Practice for the pharmaceutical industry at arm's length of the 麻豆社itself.

听

This has been superseded by the 麻豆社Code of Practice 2024.